Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019

Table 2 Chloroquine resistance marker and patient characteristics from merged 2017/2019 studies

	CQ-resistance		No CQ-resistance		p-value
	N	%	N	%	p-value
Age (year)					0.163
0–5	153	23.2	506	76.8
6–12	108	29.3	260	70.7
13–19	48	27.9	124	72.1
20 and +	93	26.1	264	73.9
Total	402	25.8	1154	74.2
Sex					0.689
Female	208	25.5	608	74.5
Male	196	26.4	547	73.6
Total	404	25.9	1155	74.1
Site					< 0.001
Bolenge	35	26.5	97	73.5
Fungurume	2	1.5	132	98.5
Kalima	7	4.8	140	95.2
Kamina	14	9.2	138	90.8
Karawa	17	12.4	120	87.6
Katana	132	86.8	20	13.2
Kingasani	112	42.4	152	57.6
KIsangani	10	5.6	170	94.4
Lubumbashi	6	4.4	131	95.6
Vanga	72	44.7	89	55.3
Number episode of malaria last 12 months					0.001
1	54	18.6	236	81.4
2	71	26.5	197	73.5
3	51	28.3	129	71.7
4 and +	52	38.2	84	61.8
Total	407	25.5	1189	74.5
Study					0.007
2017-study	218	28.5	545	71.4
2019-study	189	22.7	644	77.3
Total	407	25.5	1189	74.5

ISSN: 1471-2334